How do you weave tradition into systems built for the modern?
In Berlin's November chill, health officials from India and Germany gathered for the third time to wrestle with one of modern medicine's enduring tensions: how ancient healing traditions earn their place inside the architecture of contemporary public health. Representatives from India's Ministry of Ayush and Germany's federal health institutions spent three days not exchanging pleasantries, but negotiating the hard mechanics of evidence standards, insurance reimbursement, and regulatory harmonization. The meeting reflects a broader human question — not whether old knowledge has value, but how it proves that value to institutions built on different assumptions.
- Traditional medicine sits at an awkward threshold — respected by millions of patients but still struggling to satisfy the evidentiary demands of modern insurance and regulatory systems.
- Senior decision-makers from both nations — not diplomats, but the people who actually control funding, approvals, and coverage — convened to close the gap between recognition and access.
- Three concrete friction points dominated the talks: embedding traditional therapies into existing public health infrastructure, creating reimbursement pathways that insurers will accept, and building regulatory standards that demand proof without dismissing entire healing traditions.
- The Indian delegation toured Charite University and integrative hospitals to understand how Germany has already navigated this terrain, studying the machinery of a system that has partially solved what India is still working to solve.
- Both countries are now moving toward research collaborations, regulatory harmonization, and shared frameworks — the quiet, unglamorous work that will ultimately determine what doctors can prescribe and what patients can afford.
In mid-November, officials from India and Germany gathered in Berlin for their 3rd Joint Working Group Meeting on Alternative Medicine — three days of substantive negotiation between people who actually control what gets funded, approved, and covered. India's Ministry of Ayush sent its Joint Secretary and the directors of its major research councils. Germany fielded officials from its Federal Ministry of Health, Charite Berlin's integrative medicine center, one of its largest statutory insurers, and its drug regulatory body. These were working sessions, not ceremonies.
The problems on the table were concrete and difficult. How do you integrate traditional medicine into public health systems already built around different assumptions? How do you persuade insurance bodies to reimburse treatments that don't fit existing categories? And how do you craft regulatory standards rigorous enough to satisfy skeptics without dismissing entire medical traditions as inherently unscientific? Both sides committed to evidence-based, people-centric approaches — language that signals a refusal to pretend these systems work if they don't, but also a refusal to ignore them simply because they are old.
The Indian delegation moved through Berlin's medical landscape with deliberate curiosity — visiting Charite University to explore research partnerships and a potential memorandum of understanding, touring the Community Hospital Havelhohe to observe integrative care in practice, and meeting with Germany's Federal Joint Committee to understand the precise mechanics of insurance reimbursement.
What emerged was less a finished agreement than a shared map of the same puzzle. India wants its Ayush systems — Ayurveda, Yoga, Unani, Siddha, Homoeopathy — to enter global healthcare not as exotic alternatives but as credible, evidence-backed options. Germany, with its own long tradition of integrative medicine, wants whatever is integrated to meet serious standards. The two countries have now committed to sustained collaboration on research, regulatory harmonization, and patient access mechanisms. It is the kind of work that rarely makes headlines — but it is precisely this work that determines what healing traditions survive the crossing into modern institutional life.
In the gray Berlin autumn, officials from India and Germany sat down across three days in mid-November to talk about something that sounds simple but carries enormous weight: how to make traditional medicine work inside modern health systems. The 3rd Joint Working Group Meeting on Alternative Medicine brought together people who spend their careers at the intersection of the ancient and the contemporary—researchers, regulators, insurance executives, hospital administrators—all trying to solve the same problem from different angles.
India sent Monalisha Dash, Joint Secretary at the Ministry of Ayush, along with the directors of its Central Council for Research in Ayurveda and Siddha, its Central Council for Research in Homoeopathy, and other senior scientists. Germany fielded its own heavyweight delegation: Paul Zubeil from the Federal Ministry of Health, Georg Seifert from Charite Berlin's Competence Center for Traditional and Integrative Medicine, Andrea Galle who runs one of Germany's largest statutory health insurers, and officials from the Federal Institute for Drugs and Medical Devices. These were not ceremonial attendees. They were the people who actually make decisions about what gets funded, what gets approved, and what patients can access.
The three concrete problems they tackled tell you what's actually hard about this work. First: how do you weave traditional medicine into the public health systems that already exist? Second: how do you get insurance companies to pay for treatments that don't fit neatly into their existing categories? Third: how do you create regulatory standards that satisfy both the skeptics and the practitioners—that demand real evidence without dismissing entire medical traditions as unscientific? Both countries committed to pursuing what they called evidence-based and people-centric approaches, which is diplomatic language for: we're not going to pretend these systems work if they don't, but we're also not going to ignore them just because they're old.
During the visit, the Indian delegation moved through Berlin's medical landscape like students of a foreign system. They visited Charite University to discuss collaborative research and a potential memorandum of understanding. They toured the Community Hospital Havelhohe to see how integrative care actually functions in practice—how anthroposophic medicine, which has deep roots in German healthcare, sits alongside conventional treatment. They spent time with the Federal Joint Committee, the body that decides what Germany's insurance system will cover, drilling into the mechanics of reimbursement: what paperwork is needed, what evidence satisfies them, how long approval takes.
What emerged from these conversations was less a finished agreement than a shared recognition that both countries are trying to solve the same puzzle. India wants to export its Ayush systems—Ayurveda, Yoga, Unani, Siddha, Homoeopathy—not as exotic alternatives but as legitimate parts of global healthcare infrastructure. Germany, which has a long tradition of integrative medicine and a population that uses it, wants to ensure that whatever gets integrated meets rigorous standards. The Ministry of Ayush framed the partnership as part of a larger strategy to globalize these systems, to build the scientific frameworks that would let traditional medicine move across borders with credibility intact.
What happens next matters more than what was said. The two countries have committed to sustained collaboration on research, on harmonizing regulations so that a treatment approved in one place doesn't require complete re-evaluation in another, and on figuring out how to make these therapies accessible to patients through insurance mechanisms. It's the kind of work that doesn't make headlines but shapes what doctors can prescribe and what patients can afford. In the quiet aftermath of the Berlin meeting, that machinery began to turn.
Notable Quotes
Sustained collaboration with Germany will help accelerate research, regulatory harmonisation, and patient access to integrative healthcare solutions rooted in safety, quality, and scientific validation— Ministry of Ayush
The Hearth Conversation Another angle on the story
Why does it matter that India and Germany are talking about traditional medicine specifically? Isn't this just diplomatic theater?
No, because the real problem is structural. If you're an Ayurvedic doctor in India and you want your treatment recognized in Germany—or vice versa—you hit a wall. Different countries have different definitions of what counts as medicine, different safety standards, different insurance rules. Without alignment, these systems stay siloed.
But aren't there real safety concerns with traditional medicine? Why should Germany lower its standards?
That's exactly the point they're trying to solve. They're not lowering standards—they're trying to figure out what evidence actually proves safety and efficacy for these systems. A clinical trial designed for a pharmaceutical drug might not be the right way to measure an Ayurvedic treatment. So the question becomes: what does rigorous validation look like for traditional medicine?
And the insurance piece—why would a German insurer pay for Ayurveda?
Because Germans already use it. The demand exists. But right now there's no clear pathway for reimbursement, so patients pay out of pocket. If you can show that a treatment works and costs less than the conventional alternative, an insurer has a business reason to cover it. That's what they were discussing in Berlin.
So this is really about money and access, not philosophy?
It's both. The philosophy matters—whether you believe traditional medicine has value—but the money determines whether ordinary people can actually use it. That's why you had insurance executives in the room alongside researchers.
What's the risk if this goes wrong?
Either traditional medicine gets locked out of formal healthcare systems entirely, or it gets approved without proper scrutiny and people get hurt. India and Germany are trying to find the narrow path between those two failures.